Focus: Assess Post Infusion Viability of S303 RBCs
1 clinical trials · Condition
◉ Watch Focus: Assess Post Infusion Viability of S303 RBCs
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells (NCT01711346) | Cerus Corporation | 2012-10-01 |
Track Focus: Assess Post Infusion Viability of S303 RBCs automatically
Every clearance here is in the API, with alerts when new ones post.